THURSDAY, JUNE 30, 2016
THE INDEPENDENT STUDENT NEWSPAPER OF THE UNIVERSITY OF PENNSYLVANIA
Penn announces J.D./M.D. program The six year program will start in the 2017-2018 academic year ALIYA CHAUDHRY Staff Reporter
For those who have trouble choosing between being a doctor or a lawyer, have no fear: You can now become both at Penn. Penn Law announced the arrival of a joint J.D./M.D. program on June 6, which will begin in the 2017-2018 academic year. The program will allow students to receive an M.D. from the Perelman School of Medicine and a J.D. from Penn Law in six years. “The law touches every aspect of society, and for students, having degrees in both law and medicine is both highly beneficial to one’s career as well as to society, and a wholly unique advantage,” Penn Law Dean Ted Ruger said in the announcement on Penn Law’s website. “Having a knowledge of the law is, increasingly, an integral part of being both a physician and a biomedical research scientist,” Penn Medicine Dean J. Larry Jameson said in a news release for Penn Medicine. “The JD/MD program will empower health professionals to effectively SEE J.D./M.D. PAGE 3
PROFESSOR PROPOSES SUPERBUG CURE AWARD PAGE 5
WORTH
THE RUSH?
Study finds link between sorority rush and self-esteem AMANDA GEISER Staff Reporter
If we … would wish for our incoming classes to be truly composed of the best students Penn can find … we ought not to celebrate our yield rate.”
Sororities confer obvious social benefits — at least for those girls who make it through the rush process, according to Penn psychologist Melissa Hunt. Hunt’s study on sorority rush at Penn, published in the spring 2016 issue of Oracle: The Research
Journal of the Association of Fraternity/Sorority Advisors, found that although the women who rush and ultimately join a sorority enjoy a boost in their senses of belonging and self-esteem, those who are unsuccessful experience negative effects. Inspiration for the study came to Hunt when she read an article in The Daily Pennsylvanian about bid night, featuring many girls who were pleased with their sorority JULIO SOSA | NEWS PHOTO EDITOR
SEE RUSH PAGE 2
- Alec Ward
PAGE 4
First CRISPR trial on cancer patients approved at Penn Med
RACING TO RIO BACK PAGE
Gene therapies used for cancer research despite controversy CHASEN SHAO Staff Reporter
ANANYA CHANDRA | SPORTS PHOTO EDITOR
Penn Medicine will collaborate with the MD Anderson Cancer Center and UC San Francisco for the first-ever human trials using CRISPR gene therapy technology.
FOLLOW US @DAILYPENN FOR THE LATEST UPDATES
After receiving recent approval from the National Institutes of Health, researchers at the Perelman School of Medicine will move forward with the first-ever human trials using CRISPR gene therapy technologies. CRISPR are segments of prokaryotic DNA containing short repetitions of base sequences. With the ability to easily change DNA, scientists could theoretically slow the aging process and lengthen lives, bring back extinct species and feed the world by
changing genes in farm crops so they can grow in different places, according to CNN. The revolutionary CRISPR gene therapy technology was initially discovered in bacterium by a group of Japanese scientists and quickly took the gene therapy stage by storm. Although numerous other technologies relating to gene therapy have been developed and are currently undergoing investigation, CRISPR revolutionized genetics by becoming the first of its kind of “genome editor” with innate specificity due to a guide-RNA. Despite its potential, not all gene therapies have progressed, due to SEE CRISPR PAGE 5
ONLINE 7 DAYS A WEEK AT THEDP.COM